Skip to main content
. 2020 Sep 14;10(9):e038071. doi: 10.1136/bmjopen-2020-038071

Table 1.

Population characteristics for each sex and ethnic group (n=5113)

N Men P Women P
Inuit African European Inuit African European
n 5113 1272 579 340 1661 818 443
Age (years) 5113 45.0 (35.0 to 55.0) 37.0 (28.0 to 47.0) 47.0 (40.0 to 54.0) <0.001 43.0 (34.0 to 53.0) 38.0 (30.0 to 46.0) 47.0 (41.0 to 53.0) <0.001
Height (cm) 5092 168.5 (163.0 to 173.3) 172.9 (167.4 to 177.1) 180.7 (176.5 to 185.0) <0.001 157.0 (152.5 to 161.4) 160.1 (155.4 to 164.4) 167.5 (163.5 to 171.0) <0.001
Weight (kg) 5079 71.3 (61.8 to 82.2) 60.6 (54.7 to 67.4) 84.5 (76.8 to 95.5) <0.001 64.0 (55.1 to 75.3) 56.4 (49.8 to 64.7) 68.1 (61.2 to 76.7) <0.001
BMI (kg/m2) 5079 25.1 (22.3 to 28.7) 20.3 (18.8 to 22.4) 26.0 (23.9 to 28.9) <0.001 26.0 (22.7 to 30.2) 21.7 (19.5 to 24.9) 24.3 (22.0 to 27.5) <0.001
Waist circumference (cm) 5052 90.5 (82.5 to 101.6) 76.4 (72.5 to 82.3) 94.0 (87.4 to 101.6) <0.001 90.0 (81.0 to 101.0) 76.5 (70.9 to 84.0) 83.0 (76.0 to 90.8) <0.001
Visceral adipose tissue (cm) 5015 7.1 (5.9 to 8.9) 5.9 (5.1 to 6.9) 8.2 (6.8 to 9.9) <0.001 6.3 (5.2 to 7.7) 5.4 (4.5 to 6.5) 5.9 (5.1 to 7.4) <0.001
Subcutaneous adipose tissue (cm) 5012 2.2 (1.4 to 3.0) 0.7 (0.4 to 1.3) 2.7 (2.1 to 3.4) <0.001 3.7 (2.6 to 4.7) 1.5 (0.9 to 2.5) 3.3 (2.4 to 4.2) <0.001
Fasting glucose (mmol/L) 5105 5.7 (5.3 to 6.1) 4.8 (4.5 to 5.3) 5.6 (5.3 to 6.0) <0.001 5.5 (5.2 to 5.9) 4.9 (4.6 to 5.4) 5.4 (5.1 to 5.7) <0.001
2 hour glucose (mmol/L) 4964 5.0 (4.0 to 6.4) 5.4 (4.4 to 6.5) 5.2 (4.4 to 6.3)  0.561 5.7 (4.7 to 7.0) 5.9 (5.0 to 6.9) 5.1 (4.4 to 6.1) <0.001
Fasting insulin (pmol/L) 5049 33.0 (22.0 to 49.8) 19.0 (13.0 to 30.8) 29.5 (21.0 to 46.0) <0.001 42.0 (29.0 to 61.0) 25.0 (17.0 to 38.0) 27.5 (18.2 to 39.0) <0.001
2 hour insulin (pmol/L) 3573 64.0 (31.0 to 142.0) NA 125.0 (66.0 to 225.0) <0.001 148.0 (81.0 to 251.0) NA 162.0 (105.0 to 245.0)  0.868
HOMA-IR 5048 1.2 (0.8 to 1.9) 0.6 (0.4 to 1.0) 1.1 (0.7 to 1.7) <0.001 1.5 (1.0 to 2.2) 0.8 (0.5 to 1.2) 0.9 (0.6 to 1.4) <0.001
Diastolic blood pressure (mm Hg) 5083 80.0 (71.5 to 89.0) 74.0 (68.0 to 80.0) 80.0 (74.0 to 86.0) <0.001 76.5 (69.0 to 84.0) 73.0 (67.0 to 80.0) 75.0 (69.0 to 81.0) <0.001
Systolic blood pressure (mm Hg) 5084 131.5 (122.0 to 145.0) 120.0 (112.0 to 131.0) 125.0 (117.0 to 135.0) <0.001 122.5 (112.5 to 136.0) 116.0 (108.0 to 126.0) 116.0 (107.0 to 127.0) <0.001
Total cholesterol (mmol/L) 5057 5.8 (5.0 to 6.6) 3.9 (3.2 to 4.5) 5.4 (4.7 to 6.1) <0.001 5.8 (5.0 to 6.6) 3.8 (3.2 to 4.4) 5.2 (4.5 to 6.0) <0.001
HDL-cholesterol (mmol/L) 5035 1.5 (1.2 to 1.9) 1.1 (0.9 to 1.3) 1.3 (1.0 to 1.5) <0.001 1.7 (1.4 to 2.0) 1.1 (0.9 to 1.3) 1.5 (1.3 to 1.8) <0.001
LDL-cholesterol (mmol/L) 4997 3.6 (2.9 to 4.3) 2.3 (1.8 to 2.8) 3.4 (2.8 to 4.1) <0.001 3.5 (2.8 to 4.2) 2.2 (1.7 to 2.8) 3.1 (2.5 to 3.7) <0.001
Triglycerides (mmol/L) 5057 1.0 (0.7 to 1.4) 0.9 (0.7 to 1.2) 1.4 (1.0 to 1.9) <0.001 1.0 (0.8 to 1.4) 0.8 (0.7 to 1.1) 0.9 (0.7 to 1.3) <0.001
Glucose-lowering drugs, n (%) 5113 20 (1.6) 4 (0.7) 0 (0.0)  0.026 31 (1.9) 2 (0.2) 0 (0.0) <0.001
Blood pressure-lowering drugs, n (%) 5113 152 (11.9) 3 (0.5) 26 (7.6) <0.001 258 (15.5) 13 (1.6) 49 (11.1) <0.001
Lipid-lowering drugs, n (%) 5113 60 (4.7) 0 (0.0) 19 (5.6) <0.001 78 (4.7) 0 (0.0) 14 (3.2) <0.001
TBC1D4 variant, n (%) 4795 <0.001 <0.001
 Non-carrier 801 (70.3) 579 (100.0) 340 (100.0) 1019 (69.0) 818 (100.0) 443 (100.0)
 Heterozygous carrier 294 (25.8) 0 (0.0) 0 (0.0) 403 (27.3) 0 (0.0) 0 (0.0)
 Homozygous carrier 44 (3.9) 0 (0.0) 0 (0.0) 54 (3.7) 0 (0.0) 0 (0.0)
Current smoker, n (%) 5031 839 (66.1) 101 (18.5) 80 (23.6) <0.001 1151 (69.5) 41 (5.3) 90 (20.3) <0.001
PAEE (kJ/kg/day) 3266 55.6 (39.5 to 73.1) 76.0 (55.8 to 92.9) 42.4 (32.2 to 53.9) <0.001 45.2 (33.4 to 59.8) 64.4 (50.4 to 80.8) 39.4 (30.6 to 46.3) <0.001

Values are median (IQR) or n (%). P values are from analysis of variance or χ2 tests.

BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, homoeostasis model assessment for insulin resistance; LDL, low-density lipoprotein; PAEE, physical activity energy expenditure.